Literature DB >> 18059218

"Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction.

Susan C Abraham1, Alyssa M Krasinskas, Wayne L Hofstetter, Stephen G Swisher, Tsung-Teh Wu.   

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common nonepithelial neoplasm of the gastrointestinal tract and show a predilection for the stomach. Most are detected because of symptoms, but some are incidental findings at autopsy or surgery for other reasons. Incidental GISTs tend to be smaller at diagnosis, but even small (<1 cm) GISTs have been shown to harbor activating KIT mutations at rates similar to advanced GISTs. However, the prevalence and characteristics of small GISTs in surgical resections of the esophagogastric junction (EGJ) remains unclear. We studied 150 esophagogastric resections for esophageal or EGJ carcinomas (100 with preoperative chemoradiation and 50 untreated cases) that had been extensively embedded for histologic examination (mean 30 sections/case). Number, size, morphology, and location of all GISTs and leiomyomas were recorded. All potential GISTs were evaluated with CD117 and CD34 immunohistochemistry, and a subset (35) leiomyomas with smooth muscle actin, desmin, and CD117. We found 18 incidental GISTs in 15 of 150 (10%) patients; 3 patients harbored 2 separate lesions. Prevalence of GIST was identical in treated (10 of 100) and untreated (5 of 50) cases. All (100%) showed positivity for both CD117 and CD34 and all were of spindle cell morphology. Lesions ranged from 0.2 to 3.0 mm in size (mean 1.3 mm). Eight (44%) were based in the outer muscularis propria, 7 (39%) in inner muscularis, and 3 (17%) between the muscle layers. The lesions tended to cluster near the EGJ, with 8 (44%) on the gastric side, 9 (50%) on the esophageal side, and 1 (6%) undetermined owing to overlying ulceration. Leiomyomas were even more common than GIST, occurring in 47% of patients (44% of treated and 52% of untreated, P=0.39), with a mean of 3 leiomyomas per patient (range 1 to 13) and mean size of 1.7 mm (range 0.2 to 12 mm). Unlike colorectal leiomyomas, most (91%) EGJ leiomyomas were located in the inner muscularis propria and only rarely (1%) in muscularis mucosa. These results suggest that GIST and leiomyoma are common incidental "seedling" lesions of the EGJ, found in 10% and 47% of patients undergoing surgery for esophageal carcinoma. The common occurrence of microscopic GISTs compared with the rarity of clinically manifest and malignant esophagogastric GISTs suggests that additional genetic or epigenetic alterations must happen for neoplastic progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059218     DOI: 10.1097/PAS.0b013e31806ab2c3

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  42 in total

Review 1.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

2.  Spontaneous leiomyomas of the gastroesophageal junction in a chimpanzee (Pan troglodytes).

Authors:  Sanjeev Gumber; Melissa I Stovall; Eileen Breding; Maria M Crane
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

3.  Long-term outcomes of percutaneous endoscopic intragastric surgery in the treatment of gastrointestinal stromal tumors at the esophagogastric junction.

Authors:  Eiji Kanehira; Aya Kamei; Akiko Umezawa; Atsushi Kurita; Takashi Tanida; Masafumi Nakagi
Journal:  Surg Endosc       Date:  2015-07-23       Impact factor: 4.584

4.  Our Experience Regarding the Association Between Gastrointestinal Stromal Tumor and Bariatric Surgery: a Response to a Letter "Gastrointestinal Stromal Tumor After Laparoscopic Sleeve Gastrectomy: Be Awake Before, During, and After a Bariatric Procedure".

Authors:  Hubert Johanet; Fabien Mantilla-Sylvain; André Dabrowski; Franck Maisonnette; Robert Portet; Olivier Merlier; Philippe Malvaux
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

5.  Clinicopathological features and prognosis of 276 cases of primary small (≤ 2 cm) gastric gastrointestinal stromal tumors: a multicenter data review.

Authors:  Zifeng Yang; Xingyu Feng; Peng Zhang; Tao Chen; Haibo Qiu; Zhiwei Zhou; Guoxin Li; Kai Xiong Tao; Yong Li
Journal:  Surg Endosc       Date:  2018-11-27       Impact factor: 4.584

6.  Low prevalence of invasive adenocarcinoma and occult cancer on esophageal resection for Barrett's esophagus with high-grade dysplasia: Evidence for conservative management.

Authors:  Deepa T Patil; Thomas P Plesec; John R Goldblum
Journal:  J Gastrointest Oncol       Date:  2011-03

7.  Lymphoepithelioma-like carcinoma of the stomach with incidental gastrointestinal stromal tumor (GIST)--a rare synchrony of two tumors.

Authors:  Aanchal Kakkar; Rakesh K Gupta; Nihar R Dash; Ishrat Afshan; Vaishali Suri
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 8.  Endoscopic treatment for gastrointestinal stromal tumor: Advantages and hurdles.

Authors:  Hyung Hun Kim
Journal:  World J Gastrointest Endosc       Date:  2015-03-16

Review 9.  [Gastrointestinal stromal tumors: evolution of a tumor concept from unclassifiable neoplasms to targeted molecular therapy].

Authors:  A Agaimy; R Schneider-Stock
Journal:  Pathologe       Date:  2010-03       Impact factor: 1.011

10.  Gastrointestinal stromal tumour of the duodenum: single institution experience.

Authors:  Ashwin S Kamath; Michael G Sarr; David M Nagorney; Florencia G Que; Michael B Farnell; Michael L Kendrick; Kaye M Reid Lombardo; John H Donohue
Journal:  HPB (Oxford)       Date:  2012-08-17       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.